Thomas Ciossek
Papers
1
Total Citations
41
H-Index
1
About
Thomas Ciossek is a distinguished researcher in the fields of epigenetics and drug discovery, with a particular focus on histone deacetylase (HDAC) biology and high-throughput screening technologies. His most notable contribution is the development of a homogeneous cellular histone deacetylase assay, detailed in his highly cited 2007 paper (41 citations), which provided a robust, cell-based platform for compound profiling and robotic screening. This work significantly advanced the ability to identify and characterize HDAC inhibitors, key therapeutic agents in cancer and neurological disorders. Ciossek’s assay design bridged the gap between biochemical and cellular approaches, enabling more physiologically relevant drug discovery. His contributions have been instrumental in streamlining the preclinical evaluation of epigenetic modulators, impacting both academic research and pharmaceutical development. Through this seminal work, Ciossek has established himself as a key figure in translating epigenetic mechanisms into actionable screening tools, with his methods widely adopted for their reproducibility and scalability in automated environments.
Research Focus
Key Achievements
Top Papers
- 1